RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+13.11%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$2.29B
AUM Growth
+$2.29B
(+15%)
Cap. Flow
+$202M
Cap. Flow
% of AUM
8.84%
Top 10 Holdings %
Top 10 Hldgs %
38.35%
Holding
106
New
18
Increased
27
Reduced
10
Closed
11
Top Buys
| 1 |
New Fortress Energy
NFE
|
$35.7M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$33.6M |
| 3 |
Xperi
XPER
|
$33.1M |
| 4 |
Roivant Sciences
ROIV
|
$24M |
| 5 |
Zymeworks
ZYME
|
$23.7M |
Top Sells
| 1 |
Adeia
ADEA
|
$94.3M |
| 2 |
Apollo Global Management
APO
|
$44.2M |
| 3 |
Green Plains
GPRE
|
$29.8M |
| 4 |
FerroAtlántica
GSM
|
$27.9M |
| 5 |
Hertz
HTZ
|
$16.6M |
Sector Composition
| 1 | Healthcare | 27.59% |
| 2 | Energy | 19.67% |
| 3 | Industrials | 18.24% |
| 4 | Technology | 7.41% |
| 5 | Financials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Heron Therapeutics
HRTX
$204M
| $29.4M | 1.28% |
11,750,000
+9,233,672
| +367% | +$23.1M |
|
27
Karyopharm Therapeutics
KPTI
$61.4M
| $28.2M | 1.23% |
552,975
+286,967
| +108% | +$14.6M |
|
|
AMYT
28
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $26.3M | 1.15% |
3,600,000
| – | – |
|
29
Sutro Biopharma
STRO
$85.6M
| $26M | 1.13% |
3,211,872
+1,811,872
| +129% | +$14.6M |
|
30
ARS Pharmaceuticals
SPRY
$1.08B
| $25.5M | 1.11% |
2,990,564
+295,394
| +11% | +$2.52M |
|
31
Bausch Health
BHC
$2.72B
| $25.5M | 1.11% |
4,052,945
+788,474
| +24% | +$4.95M |
|
|
32
Roivant Sciences
ROIV
$8.6B
| $24M | 1.05% |
+3,000,000
| New | +$24M |
|
|
33
Zymeworks
ZYME
$1.07B
| $23.7M | 1.03% |
+3,018,217
| New | +$23.7M |
|
34
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $23.5M | 1.03% |
1,569,503
+123,396
| +9% | +$1.85M |
|
35
Digimarc
DMRC
$171M
| $22.5M | 0.98% |
1,214,593
| – | – |
|
36
QuinStreet
QNST
$875M
| $19.5M | 0.85% |
1,360,683
| – | – |
|
|
KDNY
37
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18.9M | 0.82% |
719,809
-229,357
| -24% | -$6.01M |
|
38
Schrodinger
SDGR
$1.42B
| $18.7M | 0.81% |
1,000,000
-77,621
| -7% | -$1.45M |
|
39
EverQuote
EVER
$841M
| $18.4M | 0.8% |
1,246,622
| – | – |
|
40
Magnachip Semiconductor
MX
$107M
| $18.3M | 0.8% |
1,950,100
| – | – |
|
41
Clear Channel Outdoor Holdings
CCO
$636M
| $18.3M | 0.8% |
17,391,427
| – | – |
|
|
HRT
42
DELISTED
HireRight Holdings Corporation
HRT
| $18.1M | 0.79% |
1,523,266
| – | – |
|
43
Meta Platforms (Facebook)
META
$1.85T
| $16.1M | 0.7% |
+133,465
| New | +$16.1M |
|
44
ANI Pharmaceuticals
ANIP
$2.06B
| $15.1M | 0.66% |
376,132
+89,086
| +31% | +$3.58M |
|
45
InterDigital
IDCC
$7.35B
| $15.1M | 0.66% |
+304,260
| New | +$15.1M |
|
|
CMRX
46
DELISTED
Chimerix, Inc.
CMRX
| $14M | 0.61% |
7,500,000
+875,000
| +13% | +$1.63M |
|
47
Alphabet (Google) Class C
GOOG
$2.79T
| $13.5M | 0.59% |
+152,315
| New | +$13.5M |
|
|
PNT
48
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $13.3M | 0.58% |
+1,827,304
| New | +$13.3M |
|
49
Ovid Therapeutics
OVID
$94.6M
| $12.7M | 0.55% |
6,828,065
+2,311,765
| +51% | +$4.3M |
|
50
ReNew
RNW
$2.78B
| $12.5M | 0.55% |
2,279,013
| – | – |
|